10194_2019_1032_MOESM1_ESM.docx (14.99 kB)
Additional file 1: of Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials
journal contribution
posted on 2019-07-25, 06:26 authored by Li Loo, Jessica Ailani, Jack Schim, Simin Baygani, Hans-Peter Hundemer, Martha Port, John KregeTable S1. Odds ratios for lasmiditan treatment versus placebo were similar or greater in the group of patients using topiramate and propranolol. (DOCX 14 kb)